# Initial Evaluation of Vascudyne Coronary Artery Bypass Conduit

> **NCT06434935** · EARLY_PHASE1 · ENROLLING_BY_INVITATION · sponsor: **Vascudyne, Inc.** · enrollment: 5 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **COMBINATION_PRODUCT:** CABA

## Key facts

- **NCT ID:** NCT06434935
- **Lead sponsor:** Vascudyne, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-06-13
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2025-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06434935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06434935, "Initial Evaluation of Vascudyne Coronary Artery Bypass Conduit". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06434935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*